Browse drug classes

Find a class, then browse its recorded medications and Ontario listing requirements.

Antivirals

Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.

ENTECAVIR: products 1 to 8 of 8.

Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.

Product / strength / formOntario listingRecorded ministry priceNext step
Accel-Entecavir
0.5mg TabDIN 02479907
Limited Use, codes 505, 506, 507, 508$4.4000per source unitRequirements & sourcesBuild cost plan
Apo-Entecavir
0.5mg TabDIN 02396955
Limited Use, codes 505, 506, 507, 508$4.4000per source unitRequirements & sourcesBuild cost plan
Auro-Entecavir
0.5mg TabDIN 02448777
Limited Use, codes 505, 506, 507, 508$4.4000per source unitRequirements & sourcesBuild cost plan
Baraclude
0.5mg TabDIN 02282224
Limited Use, codes 505, 506, 507, 508$4.4000per source unitRequirements & sourcesBuild cost plan
Entecavir
0.5mg TabDIN 02527154
Limited Use, codes 505, 506, 507, 508$4.4000per source unitRequirements & sourcesBuild cost plan
Jamp-Entecavir
0.5mg TabDIN 02467232
Limited Use, codes 505, 506, 507, 508$4.4000per source unitRequirements & sourcesBuild cost plan
Mint-Entecavir
0.5mg TabDIN 02485907
Limited Use, codes 505, 506, 507, 508$4.4000per source unitRequirements & sourcesBuild cost plan
PMS-Entecavir
0.5mg TabDIN 02430576
Limited Use, codes 505, 506, 507, 508$4.4000per source unitRequirements & sourcesBuild cost plan

Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.

Class sources and program rules

Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.

08:18 Antivirals.